UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026594
Receipt number R000030536
Scientific Title How can we collaborate effectively with multiple medical professionals by utilizing waiting time of outpatients?
Date of disclosure of the study information 2017/03/17
Last modified on 2019/05/17 14:22:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

How can we collaborate effectively with multiple medical professionals by utilizing waiting time of outpatients?

Acronym

How can we collaborate effectively with multiple medical professionals by utilizing waiting time of outpatients?

Scientific Title

How can we collaborate effectively with multiple medical professionals by utilizing waiting time of outpatients?

Scientific Title:Acronym

How can we collaborate effectively with multiple medical professionals by utilizing waiting time of outpatients?

Region

Japan


Condition

Condition

Cancer

Classification by specialty

Hematology and clinical oncology Rehabilitation medicine Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify how we can collaborate effectively with multiple medical professionals by utlilizing waiting time of outpatients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

QOL

Key secondary outcomes

Nutritional status


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

rehabilitation nutritional education

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1 out patients for chemotharapy
2 age over 20
3 written informed concent

Key exclusion criteria

1 hospitalized patient for chemotherapy
2 Patients judged as inappropriate for this study by investigators

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Utae
Middle name
Last name Katsushima

Organization

Kansai Electric Power Hospiral

Division name

Dept od Medical Oncology

Zip code

5530003

Address

2-1-7Fukushima, Fukusima-ku Osaka 553-0003

TEL

06-6458-5821

Email

katsushima.utae@d2.kepco.co.jp


Public contact

Name of contact person

1st name Utae
Middle name
Last name Katsushima

Organization

Kansai Electric Power Hospiral

Division name

Dept od Medical Oncology

Zip code

5530003

Address

2-1-7Fukushima, Fukusima-ku Osaka 553-0003

TEL

06-6458-5821

Homepage URL

https://www.kepco.co.jp/

Email

katsushima.utae@d2.kepco.co.jp


Sponsor or person

Institute

Kansai Electric Power Hospiral
Dept od Medical Oncology

Institute

Department

Personal name



Funding Source

Organization

Kansai Medical Net
Kansai Electric Power Hospiral

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kansai Electric Power Hospital

Address

2-1-7Fukushima Fukushima-ku Osaka Japan

Tel

06-6458-5821

Email

katsushima.utae@d2.kepco.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

関西電力病院 


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 17 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

120

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2017 Year 03 Month 10 Day

Date of IRB

2017 Year 03 Month 10 Day

Anticipated trial start date

2017 Year 03 Month 17 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry

2020 Year 03 Month 30 Day

Date trial data considered complete

2020 Year 03 Month 31 Day

Date analysis concluded

2020 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2017 Year 03 Month 17 Day

Last modified on

2019 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030536


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name